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Background: Caffeine has been shown to enhance exercise performance and capacity. 
The mechanisms remain unclear but are suggested to relate to adenosine receptor 
antagonism, resulting in increased central motor drive, reduced perception of effort, 
and altered peripheral processes such as enhanced calcium handling and extracellular 
potassium regulation. Our aims were to investigate how caffeine (i) affects knee extensor 
PCr kinetics and pH during repeated sets of single-leg knee extensor exercise to task 
failure and (ii) modulates the interplay between central and peripheral neural processes. 
We hypothesized that the caffeine-induced extension of exercise capacity during 
repeated sets of exercise would occur despite greater disturbance of the muscle milieu 
due to enhanced peripheral and corticospinal excitatory output, central motor drive, and 
muscle contractility.
Methods: Nine healthy active young men performed five sets of intense single-leg knee 
extensor exercise to task failure on four separate occasions: for two visits (6 mg·kg−1 
caffeine vs placebo), quadriceps 31P-magnetic resonance spectroscopy scans were 
performed to quantify phosphocreatine kinetics and pH, and for the remaining two 
visits (6 mg·kg−1 caffeine vs placebo), femoral nerve electrical and transcranial magnetic 
stimulation of the quadriceps cortical motor area were applied pre- and post exercise.
results: The total exercise time was 17.9 ± 6.0% longer in the caffeine (1,225 ± 86 s) 
than in the placebo trial (1,049 ± 73 s, p = 0.016), and muscle phosphocreatine con-
centration and pH (p < 0.05) were significantly lower in the latter sets of exercise after 
caffeine ingestion. Voluntary activation (VA) (peripheral, p = 0.007; but not supraspinal, 
p = 0.074), motor-evoked potential (MEP) amplitude (p = 0.007), and contractility (con-
traction time, p = 0.009; and relaxation rate, p = 0.003) were significantly higher after 
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caffeine consumption, but at task failure MEP amplitude and VA were not different from 
placebo. Caffeine prevented the reduction in M-wave amplitude that occurred at task 
failure (p = 0.039).
conclusion: Caffeine supplementation improved high-intensity exercise tolerance 
despite greater-end exercise knee extensor phosphocreatine depletion and H+ accu-
mulation. Caffeine-induced increases in central motor drive and corticospinal excitability 
were attenuated at task failure. This may have been induced by the afferent feedback 
of the greater disturbance of the muscle milieu, resulting in a stronger inhibitory input to 
the spinal and supraspinal motor neurons. However, causality needs to be established 
through further experiments.
Keywords: caffeine, fatigue, transcranial magnetic stimulation, neuromuscular function, central fatigue
inTrODUcTiOn
Caffeine (1, 2, 3 methylxanthine) supplementation has been 
demonstrated to improve endurance (1), high-intensity (2) and 
strength exercise capacity, and performance (3) at doses rang-
ing from 2 to 10 mg·kg−1. Caffeine is rapidly absorbed into the 
bloodstream after ingestion, with peak concentrations [~70 μM 
after 6  mg·kg−1 (4)] achieved 30–60  min after ingestion. The 
mechanisms of action remain unclear but have been suggested to 
include an increased central motor drive and a reduced perception 
of effort related to adenosine receptor antagonism (5), as well as 
an increased muscle contractility due to altered calcium kinetics 
and/or sensitivity and an improved muscle ion regulation (6, 7).
Adenosine has inhibitory effects on the central nervous system 
excitability by attenuating the release of excitatory neurotrans-
mitters and reducing neuronal-firing rates (8). Caffeine has a 
similar structure to adenosine and as a consequence is an effective 
adenosine receptor antagonist (9). Caffeine has been shown to 
increase excitatory neurotransmitter release and lower the activa-
tion threshold of cerebral cortical neurons (10), as well as increase 
serotonin levels in the serotonergic neurons of the raphe nuclei in 
the brainstem of the rat (11). This may cause an increased spinal 
motor neuron excitability since there is an excitatory input from 
the raphe nuclei at the spinal level (12). There is also evidence 
that this translates to human in  vivo physiology, since there is 
an increased incidence of self-sustained firing of tibialis anterior 
motor units after caffeine supplementation (13).
The effects of caffeine on corticospinal excitability have been 
assessed in a small number of studies using transcranial mag-
netic stimulation (TMS). The motor-evoked potential (MEP) 
amplitude was elevated in the vastus lateralis muscle sustaining a 
contraction at 3% MVC, 1 h after consuming 6 mg·kg−1 caffeine, 
and the fatigue-induced decline in MEP amplitude was attenu-
ated by caffeine (14). The extension of time-to-task failure in this 
open-ended single-leg knee extensor task after caffeine ingestion 
was correlated with MEP amplitude at the start of exercise, clearly 
implicating an increased corticospinal excitability as an impor-
tant mechanism of caffeine’s action. Caffeine has also consistently 
been shown to increase central drive, measured as knee extensor 
voluntary activation (VA), in both fresh (14, 15) and fatigued (15) 
muscle, and a meta-analysis (1) indicates a moderate- to large-
effect size of caffeine on VA (0.67 effect size).
Peripheral mechanisms are also involved in caffeine’s actions. 
In vitro studies have demonstrated improved excitation–contrac-
tion coupling via increased twitch and tetanic force produced 
during electrically evoked contractions. The mechanisms pro-
posed include the antagonism of adenosine A1 receptors on the 
muscle membrane, as well as an interaction with the ryanodine 
receptors of the sarcoplasmic reticulum (SR), thus increasing 
calcium release and myofibrillar calcium sensitivity and reduc-
ing SR Ca2+-ATPase sensitivity [for a review, see Ref. (16)]. 
However, these studies employed supraphysiological doses of 
caffeine (10 mM). More recently, both James et al. (17) and Tallis 
et  al. (18) demonstrated enhanced twitch torque in isolated 
mouse muscle at physiologically relevant concentrations (50–
70 µM). In addition, some human studies have shown increases 
in resting twitch torque amplitude and temporal characteristics 
in fresh and fatigued muscle after caffeine supplementation, 
suggesting altered calcium handling. Extracellular potassium 
accumulation is implicated in fatigue development since this 
will result in the depolarization of the resting membrane, 
resulting in a broadened action potential, a reduced conduction 
velocity, and a decreased excitability (19). Shushakov et al. (20) 
observed an inverse relationship between M-wave area and 
venous potassium concentration during fatiguing static and 
dynamic exercise. The accumulation of extracellular potassium 
normally observed during fatiguing high-intensity exercise 
seems to be attenuated after caffeine ingestion. Caffeine inges-
tion (6 mg·kg−1) attenuated the increase in interstitial potassium 
during one-legged knee extensor exercise at 20 (10  min) and 
50  W (3 ×  3  min) measured using microdialysis (21). In the 
same study, high-intensity capacity was improved by 16% after 
caffeine ingestion. Possible mechanisms are suggested to include 
elevated catecholamine concentrations that result in increased 
Na+–K+ ATPase activity, thus supporting the maintenance of 
the resting membrane potential and presumably therefore better 
preserved membrane excitability.
Caffeine affects peripheral and central neural processes and 
therefore provides an excellent tool to study the integration of 
afferent sensory information within regions upstream of the motor 
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cortex to produce an appropriate level of central motor drive to 
preserve function during fatiguing exercise. There is a lack of data 
on the effects of caffeine on muscle metabolism, and certainly no 
studies have been conducted where both muscle metabolism and 
neuromuscular function have been assessed after caffeine inges-
tion. We employed magnetic resonance spectroscopy (MRS) 
of the quadriceps to allow continuous quantification of muscle 
metabolites and pH changes during exercise. In a parallel set 
of experiments, TMS and electrical stimulation of the femoral 
nerve were utilized to assess central and peripheral neural pro-
cesses. The aim of the present study was to determine whether 
the caffeine-induced extension of time-to-task failure during 
repeated sets of high-intensity single-leg knee extensor exercise 
was related to altered interplay between central and peripheral 
neural processes and despite greater changes in the knee exten-
sor metabolites. We hypothesized that caffeine ingestion will 
extend the time-to-task failure via augmented peripheral and 
corticospinal excitatory output and central motor drive despite 
greater declines in knee extensor phosphocreatine concentration 
and pH at task failure.
MaTerials anD MeThODs
Participants
Nine male recreational athletes [age: 26.0 ± 2.7 (±SEM) years; 
height: 1.79 ±  0.02 m; weight: 78.4 ±  2.2 kg] took part in this 
double-blind part-randomized controlled study, which was 
approved by the Sport and Health Sciences Research Ethics 
Committee at the Exeter University and conducted in accordance 
with the Declaration of Helsinki. After being informed verbally 
and in writing of the experimental procedures and associated 
risks, all participants completed a medical health questionnaire 
and a screening questionnaire to ensure that there were no 
contraindications for magnetic resonance scanning and cortical 
stimulation, before providing written informed consent to the 
experimental procedures. All participants were non-smokers, 
habitual caffeine consumers, in good health, and had no known 
history of cardiovascular, metabolic, neurological, or motor 
disorder. On test days, participants were instructed to report to 
the laboratory in a rested and fasted state, having completed no 
strenuous exercise or consumed alcohol or caffeine within the 
previous 24 h.
experimental Design
After a familiarization visit, each participant completed four 
main trials in the morning, separated by between 3 and 7 days. 
In each main trial, they performed five sets of intense single-leg 
knee extensor exercise to task failure, separated by a 5-min rest. 
On the first two visits, 31P-MRS measurements of the quadriceps 
were made throughout exercise, and for the remaining two visits, 
the peripheral and corticospinal excitability and the contractility 
of the quadriceps muscle were evaluated using peripheral nerve 
electrical (PNS) and transcranial magnetic (TMS) stimulation. 
Trial order for both MRI and the neuromuscular function meas-
urement visits, placebo (glucose) or caffeine (6  mg·kg−1) was 
randomized using a sealed envelope system.
Protocol
On arrival at the laboratory for the first two visits, a cannula was 
inserted into the antecubital vein, and venous blood samples were 
collected at regular intervals throughout the protocol. In order 
to collect 31P data, a 6-cm 31P transmit/receive surface coil was 
placed within the bed of a 1.5-T whole-body MR scanner (Intera, 
Philips, The Netherlands) at the Exeter Magnetic Resonance 
Research Centre (Exeter, UK). The participants were positioned 
in a prone position such that the coil was centered over the 
quadriceps muscle of the right leg. After images were acquired 
to determine the correct positioning of the muscle relative to the 
coil, pre-acquisition steps were carried out to optimize the signal 
from the muscle under investigation. This comprised the tuning 
and matching of the coil to maximize energy transfer between 
the coil and the muscle, and an automatic shimming protocol 
to optimize the homogeneity of the local magnetic field within a 
volume that defined the quadriceps muscle.
Initial resting baseline scans for the determination of metabo-
lite concentrations were obtained with a repetition time of 20 s 
in order to avoid saturation effects and were averaged over 36 
individual spectra. Participants were then removed from the 
scanner and provided with either caffeine or placebo supple-
ment. After 1  h, they were returned to the scanner and set-up 
procedures as described for the baseline measurements repeated. 
Following 1-min of rest, participants undertook one-legged knee 
extension exercise which resulted in the lifting and lowering of 
weights via a pulley system, a well-established exercise model 
in our laboratories (22). In all cases, the weight to be lifted was 
participant-specific (8.7 ± 0.6 kg) and had been determined in 
an incremental test performed several days earlier, in which the 
weight resulting in task failure within approximately 5 min was 
selected. The extensions took place at a frequency of 0.67 Hz with 
the foot moving over a distance of ~0.22 m (each complete cycle 
lasted 1.5 s), with audio cues being presented to ensure that the 
rate of contraction was maintained at the desired value. Exercise 
was continued until task failure, as defined by the inability to 
maintain exercise with the specified rate and range of movement. 
Following a 5-min recovery, another exercise bout to task failure 
was undertaken with the process repeated until five sets had been 
completed. During the entire exercise protocol (including the 
recovery periods), 31P data were acquired every 1.5 s and phase 
cycling with four phase cycles employed, leading to a spectra 
being acquired every 6.0 s.
For the final two visits, participants returned to the laboratory, 
at the same time of the day as for the first trial. A surface EMG 
electrode was positioned over musculus vastus medialis (VM) and 
musculus biceps femoris (BF) of the right leg, to record voluntary 
EMG activity and evoked potentials. Next, the adhesive anode 
and cathodes were attached as described below for femoral nerve 
stimulation. Participants were then positioned in a mock MRI 
construction in a prone position in order to replicate the position 
during MRS measurements. In order to measure maximum knee 
extensor force (MVC) during isometric contractions while in 
the prone position adopted in this study, the right leg was flexed 
and the shin placed against a solid plastic block attached to a 
calibrated force transducer, all of which was fixated to the plinth. 
Participants were firmly strapped to the plinth at the shoulders, 
FigUre 1 | Schematic diagram of the experimental procedures. (a) One hour after consuming either caffeine (6 mg·kg−1) or placebo supplement, the participants 
completed five sets of one-legged knee extension exercise (lifting and lowering of weights via a pulley system in a prone position) to task failure in two trials, each 
consisting of two visits. On the visits in the second trial, peripheral nerve (PNS) and transcranial magnetic (TMS) stimulation protocols were performed before and 1 
h after the supplement intake, as well as after the completion of the exercise. (B,c) Examples of the EMG and twitch responses to stimulations of the PNS and  
the motor cortex (TMS) affiliated with the muscles in the upper leg recorded during maximal (100% MVC) and submaximal (75% MVC) voluntary contractions, 
respectively. The illustrated responses were recorded from the agonist [vastus medialis (VM)] and the antagonist [biceps femoris (BF)] muscles of the exercised  
leg of a representative participant. The diagram illustrates the method for the calculation of the characteristic time–amplitude parameters of the evoked responses.
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waist, hips, and mid-thigh to prevent extraneous movement. 
Isometric force produced by the knee extensors was recorded 
as participants pushed the shin toward the plinth. After identi-
fication of the optimal stimulation points for obtaining maximal 
responses in VM to PNS and TMS (see the procedure below), the 
VM M-wave recruitment curve was constructed to determine 
the maximal M-wave (Mmax). The active motor threshold (aMT) 
for TMS was then established as described below.
Participants received five single supramaximal (130% Mmax) 
PNS pulses in the resting state and five single TMS pulses at 120% 
aMT while maintaining a 5% MVC contraction before consum-
ing a pill (placebo or caffeine). PNS and TMS were repeated 
60  min after consumption of the pill, followed by nine MVCs 
each lasting about 3 s and separated by a 1-min rest (Figure 1A). 
The first MVC was non-stimulated, then during and 2 s after the 
second MVC supramaximal PNS was delivered, and during the 
third MVC supramaximal TMS was delivered. This sequence was 
then repeated twice more. Participants were then asked to per-
form 10 brief submaximal contractions at either 50 or 75% MVC 
with visual feedback of the target level and the force production 
provided. Single suprathreshold TMS pulses were delivered 
during each of these contractions. Participants then completed 
the five sets of one-legged knee extension exercise as described 
above. The PNS and TMS protocols were then repeated, com-
mencing 2 min after task failure and lasting for ~15 min, except 
that the resting femoral nerve stimulations and TMS during 5% 
MVC contractions were performed at the end of the test battery 
on this occasion (Figure 1A).
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Peripheral nerve electrical stimulation
Supramaximal single-pulse electrical stimuli (200-µs pulse dura-
tion) were delivered to the right femoral nerve with a high-voltage 
direct current stimulator (Digitimer DS7AH, Digitimer Ltd., 
Welwyn Garden City, UK). The cathode was placed in the femo-
ral triangle, 2 cm lateral to the femoral artery, and an adhesive 
anode (both 2 cm × 2 cm biotab adhesive electrodes, Boots UK 
Ltd., Nottingham, England) placed in the gluteal fold opposite 
the cathode. The cathode was systematically moved vertically 
and horizontally, and the amplitude of the compound muscle 
action potential (CMAP, M-wave) was monitored to identify the 
optimal position of the cathode for attaining maximal peak-to-
peak M-wave amplitude. The stimulation intensity, which elicited 
Mmax, was identified by increasing the femoral nerve PNS 
stimulation current intensity in 10-mA increments from 100 mA. 
All subsequent stimulations were delivered at 130% of the Mmax 
intensity to ensure supramaximal stimulations (223 ± 11 mA).
Transcranial Magnetic stimulation
Motor-evoked potentials were elicited in the knee extensor mus-
cles by TMS of the contralateral motor cortical leg area (Magstim 
200 stimulator, Magstim Company Ltd., UK). Single pulses of up 
to 2-T intensity (100% Magstim output) were delivered to the 
motor cortex through 110° double cone coil (9-cm diameter each, 
type P/N 9902-00). The optimal coil position was determined by 
moving the coil along a virtual grid lateral and posterior to the 
vertex (±3 cm) with a resolution of 1 cm until reaching a position 
at which maximal MEP amplitude in the slightly pre-activated VM 
(5% MVC) was produced with minimal stimulation intensity. To 
optimize the stimulation intensity, the stimulus–response curve 
was constructed for each subject by systematically increasing the 
TMS intensity in 5% increments from 35% output followed by 
refinement steps of 1%. The aMT was defined as the lowest TMS 
intensity, eliciting an MEP in the VM muscle of minimum 200-µV 
peak-to-peak amplitude in at least 50% of the stimulations during 
a knee extension contraction at 5% MVC (23). The stimulation 
intensity during the exercise protocols was then set to 120% aMT 
(67 ± 3% stimulator output).
Data collection
Voluntary EMG activity level, CMAPs (M-waves), and MEPs 
were recorded from VM muscle of the right leg using surface-
active bipolar bar EMG electrodes (99.9% Ag, 10-mm length, 
1-mm width, 10-mm pole spacing, CMRR >80 dB, model DE2.1, 
DelSys Inc., Boston, MA, USA). The electrode was placed over the 
muscle belly at the recommended site for surface EMG recording 
from VM muscle (24). The ground electrode was placed over 
the patella of the right leg. Double-sided adhesive interfaces and 
hypoallergenic medical tape were used to ensure the stability 
of the contact between the EMG sensor and the skin. The skin 
area underneath the EMG electrode was shaved, then exfoliated 
with abrasive gel, and cleaned with ethyl propanol to minimize 
the skin impedance. The EMG signal was preamplified (×1,000) 
and band-pass filtered between 20 and 450  Hz at the source 
(Bagnoli-8, DelSys Inc., Boston, MA, USA), and then transferred 
to a computer with a sampling frequency of 2 kHz and high-pass 
filtered at 10 Hz.
Isometric knee extension force produced during the TMS 
and PNS protocols was measured using an in-line force trans-
ducer (Model: SSM-HN-250, Interface Force Measurements, 
Crowthorne, England,) which worked under compression and 
recorded the forces applied as the participant pushed their 
lower leg down toward the bed. The force transducer was fitted 
within a bespoke assembly, which was fixed onto the mock MRI 
scanner bed. Throughout the protocol, force data were sampled 
with a frequency of 200 Hz and recorded continuously and syn-
chronously with the EMG signals in a PC via an A/D converter 
(CED 1401power, Cambridge, UK), using Spike2 data acquisition 
software (CED, Cambridge, UK) with a 16-bit resolution.
Data analysis
Data recorded during PNS and TMS protocols (visits three 
and four) were analyzed off-line using custom-written scripts 
developed in Spike2 ver.7 software (CED, Cambridge, UK), and 
an exemplar record indicating the extracted parameters of the 
evoked EMG and twitch responses is provided for illustrative 
purposes (Figures 1B,C).
Muscle Metabolites
For both baseline and exercise protocols, MRS data were quanti-
fied by peak fitting, with the assumption of prior knowledge, 
using the AMARES fitting algorithm in the jMRUI (version 3) 
software package. Spectra were fitted assuming the presence of 
the following peaks: Pi, phosphodiester, PCr, α-ATP (two peaks, 
amplitude ratio 1:1), γ-ATP (two peaks, amplitude ratio 1:1), and 
β-ATP (three peaks, amplitude ratio 1:2:1). Resting molar con-
centrations of PCr and Pi were subsequently calculated via the 
ratio of PCr:ATP and Pi:ATP from the baseline spectra, assuming 
a resting concentration of ATP of 8.2 mM (25). Intracellular pH 
was calculated using the chemical shift of the Pi spectra relative 
to the PCr peak (26).
Blood analysis
Venous blood samples were drawn into 5-mL heparinized 
syringes (Terumo Corporation, Leuven, Belgium) from a can-
nula (Insyte-W™, Becton-Dickinson, Madrid, Spain) inserted 
into the subject’s antecubital vein. The blood was analyzed for 
(lactate) and (glucose) within ~2  min of collection (YSI 2300, 
Yellow Springs Instruments, Yellow Springs, OH, USA), and pH, 
pCO2, and HCO3
− were measured using ABL90 Flex analyzer 
(Radiometer Medical, Bronshoj, Denmark).
exercise Performance
The time-to-task failure in each set of exercise for each visit was 
measured, and data were averaged across the two visits for each 
condition (placebo and caffeine). The maximum isometric knee 
extension force (MVC, N) was evaluated before and after the 
exercise protocol and calculated as the average value over a 1-s 
period around the plateau level of the highest torque achieved 
in the three non-stimulated MVCs completed at each measure-
ment time point (Figure 1A). Voluntary force (VF, N) during the 
contractions in which PNS or TMS was applied was calculated 
as the mean force level achieved during the 50 ms preceding the 
stimulation pulse delivery (Figures 1B,C).
TaBle 1 | Parameters (mean ± SEM, n = 9) of the cortical (motor-evoked 
potentials, MEPs) and peripheral electrical (compound motor action potentials, 
Mmax) and mechanical (twitch, Tw) responses evoked by peripheral electrical 
nerve (PNS) and transcranial magnetic (TMS) stimulation in resting musculus 
vastus medialis before and 1 h after ingestion of placebo or caffeine 
supplements.
Parameters Placebo caffeine
Pre-pill 1 h post pill Pre-pill 1 h post pill
i. Pns
Mmax amplitude (mV) 5.1 ± 0.7 4.6 ± 0.6 4.3 ± 0.5 3.4 ± 0.6
Mmax area (mV·ms) 33.2 ± 5.0 29.0 ± 5.5 26.6 ± 3.5 22.1 ± 4.3
Resting Tw amplitude (N) 17.3 ± 2.0 16.9 ± 2.0 16.0 ± 1.5 15.0 ± 1.2
Contraction time (ms)a 48.2 ± 6.0 54.5 ± 5.5 44.2 ± 3.3 42.5 ± 2.5
ii. TMs
MEP amplitude  
(% Mmax amplitude)
10.1 ± 2.2 8.5 ± 1.3 11.2 ± 2.3 17.9 ± 6.1
MEP area (% Mmax area) 14.6 ± 3.9 12.4 ± 2.1 13.7 ± 2.5 27.8 ± 10.8
aMain condition effect.
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excitatory Output
The peak-to-peak amplitude and the total area of the maximal 
VM M-wave (Mmax) evoked by PNS were measured pre- and 
post pill ingestion as well as after the exercise protocol at rest, 
during, and 2  s after MVC to quantify the excitability of the 
peripheral circuitry (distal motor axon, neuromuscular junction, 
and muscle fiber membrane) (Figure  1B). The corticospinal 
excitability to VM was quantified at each stimulation point by 
the MEP peak-to-peak amplitude and the total area normalized 
to the Mmax amplitude and area, respectively, as acquired at the 
corresponding activation level and time point. The excitability of 
the intracortical inhibitory pathways was assessed by the duration 
of the silent period (CSP, ms) measured between the stimulation 
point and the time when the muscle activation returned to the pre-
stimulation voluntary EMG level. This was assessed by calculating 
the RMS EMG amplitude in the 500 ms preceding the delivery of 
each TMS pulse (Figure  1C). In addition, BF EMG data were 
monitored throughout the protocol to ensure that stimulation did 
not evoke potentials within BF, demonstrating that the activation 
of antagonist motor areas did not occur (exemplar data shown in 
Figures 1B,C).
Peripheral contractility
The peripheral contractility during maximal voluntary effort was 
quantified by the maximal muscle relaxation rate (RR) which 
occurs during the TMS-evoked cortical silent period. RR was 
identified as the minimum of the time derivative of the force signal 
and normalized (1/s) to the overall force calculated as the sum of 
the VF and the evoked superimposed twitch (sTw + VF, N). The 
superimposed twitch (sTw, N) was calculated as the peak force 
increment evoked by TMS above the VF, N level (Figure  1B). 
Peripheral contractility during MVC was also assessed from 
the peak amplitude, the contraction (CT, ms), and half relaxa-
tion (HRT, ms) times of the twitch evoked by peripheral nerve 
stimulation (PNS) (Figure 1B).
Peripheral contractility was evaluated by the size of the poten-
tiated twitch (potTw, N) evoked by PNS delivered immediately 
after MVC. In addition, the twitch responses to TMS during 
contractions at 50, 75, and 100% MVC were used to estimate the 
twitch evoked by TMS (eRTw, N).
Voluntary activation
Neural drive during the VA of the motoneuron pool (VA, %) 
was evaluated from the superimposed (sTw) and the potentiated 
(potTw) twitches evoked by PNS during and 2 s after the MVCs, 
respectively, using the standard twitch interpolation equation: 
VA = (1 − sTw/potTw) × 100%. Supraspinal VA was calculated 
as VA = (1 − sTw/eRTw) × 100% (27). In compliance with the 
recent Todd et al. (28) recommendations to ensure the quality 
of the TMS data, (1) VM MEP amplitude during contractions at 
50–100% MVC was >40% Mmax; (2) BF MEP amplitude was 
small, see Figure  1C for exemplar data; (3) estimated resting 
twitches derived from linear regressions with correlation coef-
ficients of <0.8 were excluded, and on the basis of this criterion, 
supraspinal VA data are presented for only seven of nine par-
ticipants; and (4) r-values for the linear regression performed 
to determine the estimated resting twitch were 0.92  ±  0.02 
(placebo) and 0.91 ± 0.02 (caffeine) for the seven participants 
included.
statistical analyses
Data are presented as mean ±  SEM. Performance and neuro-
muscular function data were statistically analyzed by two-way 
repeated measures ANOVA (condition: placebo vs caffeine; 
time: parameter-dependent number of levels). Blood and muscle 
metabolite parameters were analyzed by three-way repeated 
measures ANOVA for main and interaction effects of condition: 
placebo vs caffeine; exercise set: one to five levels, and time 
(first 110-s exercise and Tlim, muscle data; pre- vs post-sets; 
blood data). The significant main effects were followed up with 
t-tests with Bonferroni correction for multiple comparisons, and 
significant interaction effects were followed up with post hoc two-
way ANOVA, as appropriate. The overall acceptable significance 
level of differences for all statistical tests was set at p < 0.05. The 
statistical analyses were performed in SPSS version 23 (SPSS Inc., 
Chicago, IL, USA).
resUlTs
effect of caffeine ingestion in resting 
Muscle
Mmax amplitude and area in the resting muscle were not 
significantly altered 1  h after placebo or caffeine ingestion. 
There was a tendency for MEP amplitude to increase after 
caffeine ingestion (p = 0.07, η2 = 0.353, main condition effect, 
Table  1) but the caffeine effect on MEP area (84.7 ±  48.2 vs 
14.1 ± 14.5%, p = 0.216) did not reach statistical significance. 
Peak twitch amplitude elicited by PNS in the resting muscle 
was not affected by placebo or caffeine ingestion; however, 
twitch contraction time (CT) was significantly shorter in the 
caffeine trial (−16.0 ± 5.2%, p = 0.028, main condition effect, 
Table 1).
FigUre 2 | Exercise duration and blood metabolite data. (a) Population average (±SEM, n = 9) time of exercise to task failure throughout the five sets (Ex1–Ex5) 
completed by the participants 1 h after taking caffeine (filled bars) or placebo (open bars) supplements. Changes in blood pH (D) as well as in the concentrations of 
glucose (B) and lactate (c) in the blood samples collected before and after each exercise set in the trials with caffeine (black squares) and placebo (open circles); 
ANOVA, p < 0.05: #main condition effect; *main time effect; †set × time interaction effect.
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exercise Performance
Exercise time-to-task failure was significantly longer in the 
caffeine trial (p =  0.016, main condition effect), with the total 
exercise time accrued over the five exercise sets of 17.9 ± 6.0% 
longer in the caffeine (1,225 ±  86  s) than in the placebo trial 
(1,049 ± 73 s, p = 0.016). The time-to-task failure was decreased 
by 27.1 ± 7.8% and 31.2 ± 5.5% from sets 1 to 5 in the placebo 
and caffeine trials, respectively (p  =  0.011, main time effect, 
Figure 2A). The difference between conditions remained consist-
ent across the exercise sets. Similarly, the extent of the reduction 
in the maximum isometric contraction force at task failure after 
the five sets of knee extensor exercise (p = 0.003; main time effect) 
was not different between conditions (−12.9 ±  2.9%, placebo; 
−11.4 ± 5.8%, caffeine, Table 2). EMG RMS amplitude during 
MVC decreased (p = 0.008, main time effect) and MDF increased 
(p = 0.038, main time effect) similarly after the exercise sets in 
both conditions (Table 2).
Blood Metabolite Data
Blood glucose concentration was not affected by exercise or by 
condition (Figure  2B). However, blood lactate concentration 
increased in response to exercise (p =  0.001, main time effect, 
Figure 2C), and the levels were significantly higher in the caffeine 
condition (p =  0.006, condition effect). The decrease in blood 
pH observed after the first bout of exercise in both conditions 
remained throughout the protocol (p = 0.039, main time effect, 
Figure 2D) and was not different between conditions.
Muscle Metabolite Data
Muscle PCr declined significantly during exercise (main effect of 
time, p < 0.001) and across sets (main effect of set, p < 0.001), 
and there were significant interaction effects for condition 
by set (p =  0.024), set by time (p <  0.001), and condition by 
set by time (p =  0.002; Figure  3A). Post hoc analysis revealed 
that muscle PCr concentration was significantly lower in the 
caffeine condition during sets four to five (p <  0.05). In addi-
tion, the PCr decline during the first 110  s of exercise and 
at Tlim was significantly greater in the caffeine than in the 
placebo condition during set five (p <  0.05, condition by time 
interaction).
Inorganic phosphate concentration increased significantly 
in each of the five sets (p < 0.001), but there was no significant 
condition effect or condition by time interaction effect in any of 
the five exercise sets (Figure 3B).
FigUre 3 | Muscle metabolite data. Population average (±SEM, n = 9) timeline of the changes in the concentrations of phosphocreatine (a), inorganic phosphate 
(B), and muscle pH (c) throughout the five sets of exercise (sets 1–5) completed to task failure by the participants 1 h after taking caffeine (black squares) or 
placebo (open circles) supplements. 31P-MRS spectra were calculated for every 6.0 s and are shown continuously up to 110 s of exercise together with their levels 
at the respective times of exhaustion; post hoc p < 0.05: &condition effect; §time effect; @condition by time interaction effect.
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Muscle pH decreased significantly during exercise (main effect 
of time, p < 0.001) and across sets (main effect of set, p = 0.034), 
and there were significant interaction effects for condition by 
set (p =  0.01), condition by time (p <  0.001), and set by time 
(p < 0.001, Figure 3C). Post hoc analysis revealed that pH was 
significantly lower in the caffeine condition during sets two to 
four (p < 0.05). In addition, the pH decline during the first 110 s 
of exercise and at Tlim was significantly greater in the caffeine 
than in the placebo condition during sets 1–3 (p < 0.05, condition 
by time interaction effects).
TaBle 2 | Parameters (mean ± SEM, n = 9 for all parameters except eRTw and sTw TMS where n = 7) of the musculus vastus medialis (VM) function evaluated with 
electrical peripheral nerve (PNS) and transcranial magnetic (TMS) stimulation and before (PreEx) and after (PostEx) repeated knee extensor exercise to fatigue performed 
1 h after ingestion of placebo or caffeine supplements.
Parameters stimulus Placebo caffeine
Preex Postex Preex Postex
i. resting muscle
potTw amplitude (% MVC)a PNS 24.7 ± 1.8 20.4 ± 2.1 24.4 ± 1.3 18.5 ± 1.5
eRTw (%MVC)a TMS 21.2 ± 6.5 17.6 ± 4.6 22.5 ± 5.0 16.1 ± 3.8
ii. Knee extensors performing maximal voluntary isometric contraction (MVc)
Force (N)a 433.7 ± 25.6 376.0 ± 21.6 453.6 ± 12.5 402.0 ± 20.5
VM EMG MDF (Hz)a 81.3 ± 6.8 92.4 ± 9.1 87.5 ± 8.0 94.2 ± 7.4
VM EMG RMS amplitude (mV)a 0.22 ± 0.03 0.18 ± 0.01 0.21 ± 0.03 0.15 ± 0.02
VM EMG RMS amplitude (%Mmax)c 4.04 ± 0.71 4.68 ± 1.09 4.84 ± 0.64 3.82 ± 0.72
sTw amplitude (% MVC)b PNS 3.7 ± 1.1 3.7 ± 0.9 2.5 ± 0.5 2.1 ± 0.5
sTw amplitude (% MVC) TMS 2.3 ± 0.6 2.0 ± 0.7 1.2 ± 0.3 1.7 ± 0.4
CT (ms)b PNS 29.3 ± 3.8 29.9 ± 3.4 23.6 ± 2.3 24.9 ± 2.9
CT (ms) TMS 26.5 ± 3.2 21.4 ± 0.4 17.3 ± 2.3 18.3 ± 2.7
HRT (ms) PNS 17.5 ± 0.8 17.4 ± 1.9 17.0 ± 1.1 15.3 ± 1.7
RR (1 s−1)a,b TMS −11.4 ± 1.0 −12.1 ± 1.3 −12.5 ± 0.9 −14.9 ± 0.9
VM CSP (ms) TMS 201.5 ± 17.3 201.3 ± 15.4 210.3 ± 16.8 209.5 ± 22.1
potTw, potentiated twitch; sTw, twitch superimposed during MVC; eRTw, estimated resting twitch; MDF, median frequency of the EMG power spectral density; Mmax, maximal 
M-wave amplitude; CT, twitch contraction time; HRT, twitch half relaxation time; RR, twitch relaxation rate; CSP, cortical silent period.
aMain time effect.
bMain condition effect.
cInteraction effect.
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effect of caffeine on Peripheral 
contractility before and after exercise  
to Task Failure
Twitch Force in Relaxed Muscle
The amplitudes of the potentiated twitch (potTw) normalized 
to MVC (p <  0.001, main effect of time) and the normalized 
estimated resting twitch evoked by PNS and TMS, respectively, 
were lower after the fatiguing exercise (p = 0.01, main effect of 
time), but there was no difference between conditions (Table 2).
Twitch Parameters during MVC
The normalized peak twitch elicited during an MVC by PNS 
was smaller (p =  0.024, main condition effect, Table  2) in the 
caffeine than in the placebo trial but was not significantly altered 
by exercise. Normalized peak twitch elicited during an MVC by 
TMS was not affected by exercise or caffeine (Table 2). The CTs 
of the twitch evoked with PNS (p = 0.009, main condition effect) 
were shortened and tended to be shortened with TMS (p = 0.091, 
η2 = 0.316, main condition effect) in the caffeine trial relative to 
those in the placebo trial. The twitch RR evaluated with TMS 
increased after fatiguing exercise in both conditions (p = 0.006, 
main time effect) but was significantly faster in the caffeine trial 
(p = 0.003, main condition effect). The HRT time of the twitch 
evoked with PNS was not significantly affected by caffeine or 
fatiguing exercise (Table 2).
effect of caffeine on Peripheral Muscle 
excitability before and after exercise to 
Task Failure
In relaxed muscle, both Mmax amplitude (p = 0.03, condition 
× time interaction, Figure 4A) and area (p = 0.049; condition × 
time interaction, Figure 4C) increased after fatiguing exercise 
in the caffeine trial but decreased in the placebo trial. Caffeine 
prevented the reduction in M-wave amplitude and area dur-
ing MVC that occurred after fatiguing exercise in the placebo 
trial (both p  =  0.039, condition × time interaction effect, 
Figures 4B,D).
effect of caffeine on corticospinal 
excitability before and after exercise  
to Task Failure
Motor-evoked potential amplitude and area evoked by TMS in 
the muscle maintaining a low-level contraction (~5% MVC) were 
not significantly affected by caffeine supplementation or fatigu-
ing exercise (Figures 5A,C). By contrast, the MEP amplitude in 
the maximally contracting muscle was significantly higher pre-
exercise in the caffeine than in the placebo condition (post hoc 
analysis, p = 0.007) and tended to increase by 17.0 ± 12.8% in 
the placebo trial but to decrease on average by −20.1 ± 8.4% in 
the caffeine trial after the fatiguing exercise (p = 0.09, η2 = 0.323, 
condition × time interaction) such that MEP amplitudes were 
similar in both conditions at volitional fatigue (Figure  5B). 
However, neither MEP area during MVC (Figure 5D) nor corti-
cal silent period (Table 2) was affected significantly by caffeine or 
fatiguing exercise.
effect of caffeine on Va before and after 
exercise to Task Failure
Peripheral VA was significantly higher in the caffeine than in 
the placebo trial (p = 0.007, main condition effect, Figure 6A). 
Cortical VA also tended to be higher in the caffeine than in the 
FigUre 4 | EMG responses to peripheral nerve stimulation in fresh and fatigued musculus vastus medialis. Population average (±SEM, n = 9) peak-to-peak 
amplitude (a,B) and total area (c,D) of the maximal compound muscle action potentials (Mmax) were calculated from the EMG responses evoked by 
suprathreshold (130% Mmax) femoral nerve stimulation. The femoral nerve was stimulated with five single pulses at rest (a,c) and during maximal voluntary 
contractions (B,D) performed before (PreEx) and after (PostEx) the completion of the exercise protocol to task failure. The exercise was conducted 1 h after 
ingestion of either caffeine (filled bars) or placebo (empty bars) supplement; $condition × time interaction effect, p < 0.05.
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placebo trials before exercise but declined to a greater extent dur-
ing exercise (p = 0.074, η2 = 0.437, condition × time interaction 
effect, Figure 6B). EMG RMS amplitude normalized to Mmax 
amplitude was higher pre-exercise and lower at task failure in the 
caffeine than in the placebo trial (p =  0.033, condition × time 
interaction effect, Table 2).
DiscUssiOn
Peripheral and central neural processes were both involved in 
the caffeine-induced extension of time-to-task failure (~18%) 
in each of the five high-intensity knee extensor exercise sets. 
Caffeine increased pre-exercise central excitability and motor 
drive as indicated by the elevated corticospinal excitability and 
peripheral VA, thus allowing participants to continue to exercise 
beyond the degree of metabolic perturbation achieved in the 
placebo trial, with significantly lower muscle (PCr) and pH evi-
dent at task failure in the caffeine trial. Corticospinal excitability 
and supraspinal VA declined to similar levels at task failure in 
both conditions, collectively implicating central mechanisms, 
possibly adenosine receptor antagonism. The extended exercise 
time in the caffeine trials resulted in greater peripheral metabolic 
perturbations (lower muscle PCr and pH) but these were accom-
panied with the better preservation of peripheral membrane 
excitability at task failure, most likely due to the previously 
observed reductions in interstitial potassium accumulation. In 
addition, muscle contractility was enhanced after caffeine inges-
tion with faster muscle contraction and RRs indicative of altered 
myofibrillar calcium kinetics and sensitivity. Similar levels of VA 
and corticospinal excitability were evident at task failure in both 
caffeine and placebo conditions, despite greater disturbance of 
the metabolic milieu. Collectively, the current data indicate that 
caffeine-induced increases in central motor drive and corticospi-
nal excitability were attenuated at task failure. This may have been 
induced by the afferent feedback of the greater disturbance of 
the muscle milieu, resulting in a stronger inhibitory input to the 
spinal and supraspinal motor neurons. However, causality needs 
to be established through further experiments.
Caffeine has consistently been shown to improve the perfor-
mance of short-term high-intensity exercise (2). There is a grow-
ing consensus that the ergogenic effects are centrally mediated 
through the antagonism of adenosine receptors (5). It is suggested 
that this causes increased central drive due to an increased excita-
tory neurotransmitter release and central excitatory input, thus 
lowering alpha-motoneuron activation threshold and increasing 
neural excitability (12, 13). In the present study, caffeine ingestion 
increased peripheral VA, as well as EMG RMS amplitude normal-
ized to the maximal M-wave amplitude in fresh muscle, indicat-
ing increased central drive, most likely via optimized motor unit 
recruitment and firing rates. The elevation in MEP amplitude 
in fresh muscle maintaining either a brief maximal contraction 
or a very low-level contraction (5% MVC) provides evidence of 
the increased corticospinal excitability anticipated to result from 
adenosine receptor antagonism. At task failure, supraspinal VA 
and corticospinal excitability were similar for both conditions, 
although it took ~30% longer to reach this point in the caffeine 
FigUre 5 | EMG responses to motor cortical stimulation in fresh and fatigued musculus vastus medialis. Population average (±SEM, n = 9) peak-to-peak 
amplitude (a,B) and total area (c,D) of the motor-evoked potentials (MEPs) were calculated from the EMG responses evoked by the transcranial magnetic 
stimulation (TMS) of the motor cortex area affiliated with the lower limb muscles and normalized to the respective parameters of the maximal compound muscle 
action potentials (Mmax) evoked during maximal voluntary contractions (MVCs) by suprathreshold (130% Mmax) femoral nerve stimulation. The motor cortex was 
stimulated during low (5% MVC) and maximal (100% MVC) voluntary contractions performed before (PreEx) and after (PostEx) the completion of the exercise 
protocol to task failure. The exercise was conducted 1 h after ingestion of either caffeine (filled bars) or placebo (empty bars) supplement. At each stimulation point, 
five single TMS pulses were delivered at suprathreshold intensity (120% of the active motor threshold identified at a muscular contraction of 5% MVC strength); 
post hoc p < 0.05: §condition effect.
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trial. This suggests that the caffeine-induced increases in central 
excitability and drive are pivotal for the observed ergogenic 
effects. The extended exercise time and greater contractile work 
observed in the caffeine trial occurred despite greater metabolic 
perturbations. A modulatory influence is exerted on the spinal 
motoneurons and supraspinal drive by sensory feedback from 
group III and IV muscle afferents regarding changes in the muscle 
metabolites, including PCr depletion and accumulation of H+ and 
Pi (29). It seems that task failure occurred when caffeine-induced 
increases in central motor drive were canceled by the stronger 
FigUre 6 | Voluntary activation (VA) in fresh and fatigued knee extensors. Population average (±SEM, %) values of the peripheral (n = 9) (a) and supraspinal (n = 7) 
(B) VA were calculated using the standard twitch interpolation equations from the twitch responses to peripheral femoral nerve (PNS) and transcranial magnetic 
(TMS) stimulation. Stimulation pulses were delivered during and 2 s after the maximal voluntary contractions performed before (PreEx) and after (PostEx) the exercise 
to task failure. The exercise was completed 1 h after ingestion of either caffeine (filled bars) or placebo (empty bars) supplement; p < 0.05: #main condition effect.
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inhibitory input via the muscle afferents to prevent perturbation 
of the muscle milieu beyond a “critical threshold” (30).
In contrast to corticospinal excitability (MEP amplitude), 
peripheral excitability (Mmax amplitude) was not affected by 
caffeine ingestion in fresh muscle, which supports the importance 
of the spinal and supraspinal processes to caffeine’s ergogenic 
effects. However, caffeine ingestion resulted in the better preser-
vation of peripheral excitability in maximally contracting muscle 
and increased peripheral excitability in the relaxed muscle after 
task failure. The accumulation of extracellular potassium Ko
+( ) 
has been implicated in the loss of peripheral excitability dur-
ing high-intensity exercise. In vitro studies find that twitch and 
tetanic force declines as K+ exceeds 8 mM and contractile force 
is eliminated at 12 mM K+ (31). In vivo studies support these 
findings with reports of muscle interstitial K+ concentrations 
of 10–12  mM at the point of exhaustion after intense exercise 
(21, 32, 33). This deterioration in function seems to be related to 
a progressive depolarization of the resting membrane potential 
(31) which would reduce M-wave amplitude (34). Unfortunately, 
neither venous nor interstitial (K+) was measured in the present 
study, but Mohr et al. (21) demonstrated that caffeine ingestion 
both improved exercise performance and attenuated the increase 
in interstitial potassium during single-leg knee extensor exercise, 
similar to that employed in the present study. The preservation of 
peripheral excitability in the caffeine condition may therefore be 
attributable to reduced Ko
+ accumulation.
In addition, muscle pH was significantly lower in the caffeine 
condition in the present study, and low pH may reinforce the 
potassium efflux via the opening of pH-sensitive K+-channels 
(33, 35) and therefore contribute to peripheral fatigue caused by 
interstitial K+  accumulation. However, despite this, peripheral 
excitability was higher in the caffeine condition at task failure. 
Interestingly, in vitro acidosis has been demonstrated to preserve 
T-tubule excitability through lower Cl conductance, which 
reduces the magnitude of Na+  current required to propagate 
an action potential (36). Using a preparation from rat extensor 
digitorum longus (EDL) muscle, Hansen et al. (37) demonstrated 
that lactic acid and catecholamines are each able to counteract 
the detrimental effect of Ko
+ accumulation on membrane excit-
ability. The former through lower Cl− conductance and the 
latter via enhanced Na(+)−K+ pump activity via adenylate 
cyclase signaling. However, these mechanisms have not yet been 
confirmed in the human in vivo setting and will be offset by the 
well-documented detrimental effects of low pH on enzyme activ-
ity and metabolism.
The temporal parameters of the twitch evoked by PNS or 
TMS in relaxed muscle and during maximal contractions were 
the main measures employed in the present study to evaluate the 
effect of caffeine on fatigue-induced changes in muscle contrac-
tility during exercise. CT was consistently shorter after caffeine 
ingestion both in fresh and in fatigued muscle, indicating faster 
Ca2+ release or greater Ca2+ sensitivity. Tarnopolsky and Cupido 
(4) also found that contractility was increased after caffeine inges-
tion. Specifically, the twitch amplitude induced by low-frequency 
stimulation trains delivered to the common peroneal nerve dur-
ing dorsiflexion was increased after caffeine ingestion in healthy 
male participants, which was attributed to increased Ca2+ release 
from the SR. Tallis et al. (18) found that twitch force in isolated 
mouse soleus and EDL was elevated by 6% at physiologically rel-
evant levels as 50–70 µM (caffeine) with effects observed during 
shortening, thus implicating Ca2+ release. In the present study, 
RR, which is suggested to be indicative of Ca2+ reuptake into the 
SR, was accelerated by caffeine and was also faster in the fatigued 
muscle in both conditions. Most likely, this is due to increased 
muscle temperature, which has been shown to increase RR (38) 
and counteract the fatigue-induced slowing of the muscle RR. 
Although not measured in the present study, muscle temperature 
is anticipated to be higher in the caffeine condition, due to 30% 
longer exercise duration in the caffeine condition, and we cannot 
eliminate the influence of this factor on the observed neuromus-
cular effects of caffeine.
In conclusion, caffeine supplementation extended the time-to-
task failure during high-intensity knee extensor exercise despite 
greater changes in muscle metabolites, due to modulation of 
the interplay between central and peripheral neural processes. 
Central motor drive and corticospinal excitability were enhanced 
after caffeine ingestion, which allowed exercise to continue 
beyond the degree of muscle acidosis and PCr depletion achieved 
in the placebo trial. Caffeine preserved peripheral excitability at 
task failure probably due to lesser Ko
+ accumulation and lower 
pH, allowing the maintenance of the generation and conduction 
of the membrane potentials. Contractility was also enhanced by 
caffeine supplementation in both fresh and fatigued muscle, most 
likely due to faster Ca2+ release. Caffeine is a potent stimulant that 
extends time-to-task failure and hence allows greater disturbance 
of the muscle milieu to occur before task failure, thus improving 
exercise performance.
eThics sTaTeMenT
Nine male recreational athletes [age: 26.0 ± 2.7 (±SEM) years; 
height: 1.79 ±  0.02 m; weight: 78.4 ±  2.2 kg] took part in this 
double-blind randomized controlled study, which was approved 
by the Sport and Health Sciences Research Ethics Committee 
at the Exeter University and conducted in accordance with the 
Declaration of Helsinki. After being informed verbally and in 
writing of the experimental procedures and associated risks, all 
participants completed a medical health questionnaire and a 
screening questionnaire to ensure that there were no contraindi-
cations for magnetic resonance scanning and cortical stimulation, 
before providing written informed consent to the experimental 
procedures.
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